Literature DB >> 22720224

Targeting platelet function to improve drug delivery.

Mélanie Demers1, Denisa D Wagner.   

Abstract

Thrombocytopenia-induced tumor hemorrhage improves drug delivery to tumors. This phenomenon presents a new way to increase drug efficacy with minimal side effects. Combining anti-platelet treatment with therapeutic drugs may help us in the search for more effective ways to fight cancer.

Entities:  

Year:  2012        PMID: 22720224      PMCID: PMC3376975          DOI: 10.4161/onci.1.1.17962

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  9 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 2.  Contribution of platelets to tumour metastasis.

Authors:  Laurie J Gay; Brunhilde Felding-Habermann
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

3.  Increased efficacy of breast cancer chemotherapy in thrombocytopenic mice.

Authors:  Mélanie Demers; Benoit Ho-Tin-Noé; Daphne Schatzberg; Janie J Yang; Denisa D Wagner
Journal:  Cancer Res       Date:  2011-01-06       Impact factor: 12.701

Review 4.  How platelets safeguard vascular integrity.

Authors:  B Ho-Tin-Noé; M Demers; D D Wagner
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

Review 5.  Adoptive cell transfer: a clinical path to effective cancer immunotherapy.

Authors:  Steven A Rosenberg; Nicholas P Restifo; James C Yang; Richard A Morgan; Mark E Dudley
Journal:  Nat Rev Cancer       Date:  2008-04       Impact factor: 60.716

6.  Platelet granule secretion continuously prevents intratumor hemorrhage.

Authors:  Benoit Ho-Tin-Noé; Tobias Goerge; Stephen M Cifuni; Daniel Duerschmied; Denisa D Wagner
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

Review 7.  Cancer immunotherapy by dendritic cells.

Authors:  Cornelis J M Melief
Journal:  Immunity       Date:  2008-09-19       Impact factor: 31.745

8.  Innate immune cells induce hemorrhage in tumors during thrombocytopenia.

Authors:  Benoit Ho-Tin-Noé; Carla Carbo; Mélanie Demers; Stephen M Cifuni; Tobias Goerge; Denisa D Wagner
Journal:  Am J Pathol       Date:  2009-09-03       Impact factor: 4.307

9.  Inflammation induces hemorrhage in thrombocytopenia.

Authors:  Tobias Goerge; Benoit Ho-Tin-Noe; Carla Carbo; Charaf Benarafa; Eileen Remold-O'Donnell; Bing-Qiao Zhao; Stephen M Cifuni; Denisa D Wagner
Journal:  Blood       Date:  2008-02-06       Impact factor: 22.113

  9 in total
  9 in total

Review 1.  Towards the Manufacture of Megakaryocytes and Platelets for Clinical Application.

Authors:  Anja Baigger; Rainer Blasczyk; Constanca Figueiredo
Journal:  Transfus Med Hemother       Date:  2017-05-23       Impact factor: 3.747

2.  Perfluorocarbon nanoparticle-mediated platelet inhibition promotes intratumoral infiltration of T cells and boosts immunotherapy.

Authors:  Zaigang Zhou; Baoli Zhang; Wenjing Zai; Lin Kang; Ahu Yuan; Yiqiao Hu; Jinhui Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-29       Impact factor: 11.205

3.  Design principles for clinical efficacy of cancer nanomedicine: a look into the basics.

Authors:  Shiladitya Sengupta; Ashish Kulkarni
Journal:  ACS Nano       Date:  2013-04-23       Impact factor: 15.881

4.  Responsive and activable nanomedicines for remodeling the tumor microenvironment.

Authors:  Yinlong Zhang; Xuexiang Han; Guangjun Nie
Journal:  Nat Protoc       Date:  2020-12-11       Impact factor: 13.491

Review 5.  Trial Watch: Proteasomal inhibitors for anticancer therapy.

Authors:  Florine Obrist; Gwenola Manic; Guido Kroemer; Ilio Vitale; Lorenzo Galluzzi
Journal:  Mol Cell Oncol       Date:  2014-12-01

6.  Damaging Tumor Vessels with an Ultrasound-Triggered NO Release Nanosystem to Enhance Drug Accumulation and T Cells Infiltration.

Authors:  Yan Xu; Jiwei Liu; Zhangya Liu; Guoguang Chen; Xueming Li; Hao Ren
Journal:  Int J Nanomedicine       Date:  2021-04-01

Review 7.  Recent advances of nanotechnology-based tumor vessel-targeting strategies.

Authors:  Dongjie Zhu; Yang Li; Zhengjia Zhang; Zeyu Xue; Zhenglai Hua; Xinyi Luo; Ting Zhao; Cheng Lu; Yuanyan Liu
Journal:  J Nanobiotechnology       Date:  2021-12-20       Impact factor: 10.435

8.  Antagonism of sorafenib and regorafenib actions by platelet factors in hepatocellular carcinoma cell lines.

Authors:  Rosalba D'Alessandro; Maria G Refolo; Catia Lippolis; Grazia Giannuzzi; Nicola Carella; Caterina Messa; Aldo Cavallini; Brian I Carr
Journal:  BMC Cancer       Date:  2014-05-21       Impact factor: 4.430

9.  Glycoprotein VI in securing vascular integrity in inflamed vessels.

Authors:  Yacine Boulaftali; Marie-Anne Mawhin; Martine Jandrot-Perrus; Benoît Ho-Tin-Noé
Journal:  Res Pract Thromb Haemost       Date:  2018-04-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.